A randomized, placebo-controlled, double-blind study of the use of dutasteride for improving peri-operative and long-term outcomes of photoselective vaporization of the prostate (DOP study).

Trial Profile

A randomized, placebo-controlled, double-blind study of the use of dutasteride for improving peri-operative and long-term outcomes of photoselective vaporization of the prostate (DOP study).

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2009

At a glance

  • Drugs Dutasteride (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Acronyms DOP
  • Most Recent Events

    • 01 Nov 2009 Results have been published in the Journal of Urology.
    • 01 Nov 2009 Status changed from active, no longer recruiting to completed according to results published in the Journal of Urology.
    • 18 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top